US Patent 7709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines
Patent 7709502 was granted and assigned to Celgene on May, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 12, 2006
0
Date of Patent
May 4, 2010
0
Patent Application Number
11401858
0
Patent Citations Received
Patent Inventor Names
David I. Stirling
0
George W. Muller
0
Roger Shen-Chu Chen
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7709502 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
